Business
Eli Lilly and Incyte's Rheumatoid Arthritis Drug Baricitinib Reduced the Risk of Death ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Eli Lilly and Incyte’s rheumatoid arthritis drug baricitinib reduced the risk of death from Covid-19 in a large U.K. study ...'
Eli Lilly and Incyte’s rheumatoid arthritis drug baricitinib reduced the risk of death from Covid-19 in a large U.K. study https://t.co/f7ZWCbYOEN— Bloomberg (@business) March 3, 2022
(The above story first appeared on LatestLY on Mar 04, 2022 12:22 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
